Biocorrx (BICX) Stock Price, News & Analysis
Company Description
Biocorrx (OTC Link: BICX) is classified in the medical care facilities industry within the Healthcare sector and carries a market capitalization of $4.4M.
BICX has declined 62.9% over the past year. Shares last traded at $0.1520.
For FY2025, Biocorrx reported revenue of $797K with net income of -$3.4M and diluted earnings per share of -$0.19. The company operates at a net profit margin of -431.5%.
This page collects what Stock Titan holds for BICX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Biocorrx (BICX) stock last closed at $0.1520. Over the past 12 months, the stock has lost 62.9%. At a market capitalization of $4.4M, BICX is classified as a micro-cap stock with approximately 29.1M shares outstanding.
BICX Rankings
Latest News
Biocorrx has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include management, fda approval, clinical trial. View all BICX news →
SEC Filings
Biocorrx has filed 5 recent SEC filings, including 3 Form 10-Q, 1 Form 8-K, 1 Form 10-K. The most recent filing was submitted on August 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BICX SEC filings →
Financial Highlights
Biocorrx generated $797K in revenue in FY2025, operating income reached -$4.8M (-606.0% operating margin), and net income was -$3.4M, reflecting a -431.5% net profit margin. Diluted earnings per share stood at -$0.19. The company generated -$2.3M in operating cash flow. With a current ratio of 0.10, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Biocorrx (BICX) currently stands at 1.7 thousand shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since August 2025, short interest has decreased by 59.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Biocorrx (BICX) currently stands at 1.0 days, down 28.1% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 90.8% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 127.8 days.
BICX Company Profile & Sector Positioning
Biocorrx (BICX) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BICX often look at related companies in the same sector, including Veltex (VLXC), Xcelerate Inc (XCRT), Aesthetic Medical International Holdings Group Ltd (PAIYY), Numinus Wellness Inc. (NUMIF), and Selectis Health Inc (GBCS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BICX's relative position within its industry.